Hyaluronidase-expressing oncolytic virus VCN-11 shows promise as cancer immunotherapeutic May 17, 2022
BioAge develops small-molecule NLRP3 inhibitors for inflammatory and age-related diseases May 16, 2022
SHP-2 inhibitor NSC-87877 ameliorates clinical symptoms of MuSK-induced myasthenia gravis May 16, 2022
SOM signs licensing agreement with University of Minnesota to support muscular dystrophy work May 16, 2022
MuSK-CAARTs demonstrate promising safety and activity in models of MuSK myasthenia gravis May 16, 2022
RSS